Study Group: Aranesp Prescribers for Red Blood Cell Disorders (US)

Council Members in this Study Group: 56

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Donald Fleming, Director of the Cancer Care Center , DAVIS HEALTH SYSTEM, INC.Donald Fleming

Director of the Cancer Care Center
DAVIS HEALTH SYSTEM, INC.

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Donald Fleming, MD, is presently the Director of the Cancer Care Center for the Davis Health System. He was the Head of Hematology-Oncology at the Medical Center of Vincennes until mid 2008. Previously, Dr. Fleming was a Tenured Professor in the Division...

Edward Littman

Former Medical Director
DVA RENAL HEALTHCARE, INC.

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Edward Littman, MD, has been a Medical Director of dialysis units in Norwalk, CT since 1972, including Norwalk Hospital, Gambro Healthcare & recently retired from DaVita. He has also served as a Clinical Associate Professor of Medicine at the Yale University...

Richard Amerling, Associate Professor of Clinical Medicine, Albert Einstein College of Medicine Richard Amerling

Associate Professor of Clinical Medicine
Albert Einstein College of Medicine

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at Beth Israel Medical Center in New York City. He is also an Associate Professor of Clinical Medicine at Albert Einstein College of Medicine as well as...

Michael Flamm

Director of the Oupatient Hematology
THE NEW YORK AND PRESBYTERIAN HOSPITAL

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael Flamm, MD, PhD, is the Director of the Outpatient Hematology Clinic at the Columbia Presbyterian campus of the New York Presbyterian Hospital. He has expertise in the treatment of sickle cell anemia and paroxysmal nocturnal hemoglobinuria, and...

Members in this Study Group include these company types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Other Freestanding Healthcare Facility
  • Academic Institution*
  • Facility, Academic Medical Center
  • Non-Academic Community Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Owner
  • Chief Executive Officer
  • Partner
  • Director
  • Medical Director
  • Professor